Automates to improve speed, enable compliance, and support scalability PORTSMOUTH, N.H. , Oct.
31, 2024 /PRNewswire/ -- Loftware, the global leader in Enterprise Labeling and Artwork Management solutions, and Signant Health, the leader in evidence generation for modern clinical trials, today announced the general availability of their integrated solution. This new offering connects the Loftware Cloud Clinical Trials platform with Signant Health's GxP Inventory Clinical Supplies Management application . The new integration supports automation in three key areas.
Firstly, it allows clinical trial master data held in GxP Inventory to be transferred into the Loftware Cloud Clinical Trials platform, removing the risk of errors from manual entry processes. Secondly, print requests can be created and approved directly within the GxP Inventory application, thereby improving efficiency and usability. Finally, print status updates are then sent back from Loftware Cloud Clinical Trials to GxP Inventory automatically, ensuring that forward processes in manufacturing can be initiated promptly.
"We've seen explosive growth in direct-to-site and direct-to-patient clinical trial supply models, as well as requests for just-in-time packaging to accommodate advanced medicinal products," said Oliver Cunningham , vice president of supplies management solutions at Signant. "Loftware's industry-leading labeling capabilities, integrated with our SmartSignals Supplies solution and user workflows, off.
